2012 News Releases
Apr 16, 2012:
iCo Therapeutics Announces Year End 2011 Financial Results
Mar 28, 2012:
iCo Therapeutics and JDRF Team Up to Support Phase II Clinical Trial iDEAL for Diabetic Macular Edema
Mar 27, 2012:
iCo Therapeutics CEO to Present at Retinal Physician Symposium 2012
Mar 5, 2012:
iCo Therapeutics Appoints Douglas Janzen to Board of Directors
Jan 17, 2012:
iCo Therapeutics Retains Crescendo Communications
Copyright 2010 ICO Therapeutics | Disclaimer